SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury
SeaStar Medical Holding Corporation received dedicated ICD-10-PCS codes from the Centers for Medicare & Medicaid Services for its Selective Cytopheretic Device therapy, enabling standardized inpatient billing for the treatment of acute kidney injury. These codes, effective October 1, 2026, address previous limitations and are expected to streamline the reimbursement process for hospitals using the QUELIMMUNE therapy.
Key figures
- Adult aki market size
- $4.5 billion
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.